Study Stopped
recruitment difficulties
Diagnostic Performance of Dual Energy CT for the Detection of Gallbladder Gallstones
DUAL-GB
1 other identifier
interventional
115
1 country
1
Brief Summary
To assess diagnostic performance of Dual Energy CT fo gallblader gallstone detection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2023
CompletedFirst Posted
Study publicly available on registry
January 30, 2023
CompletedStudy Start
First participant enrolled
July 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2024
CompletedSeptember 23, 2024
September 1, 2024
1.2 years
January 17, 2023
September 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gallstone detection using Dual Energy CT
Number - size of gallstones
Day 0
Secondary Outcomes (1)
Gallstone detection using reconstruction to conventionnal KeV.
Day 0
Study Arms (1)
gallblader ultrasound
OTHERInterventions
Eligibility Criteria
You may qualify if:
- patient referred to the radiology department for an abdominal CT for abdominal pain, suspicion of cholangitis, cholecystitis, migration of stones, acute pancreatitis, suspicion of perforated ulcer in the emergency setting.
- Non-objection of the subject to participate in the study
- Affiliation to a French social security scheme or beneficiary of such a scheme.
You may not qualify if:
- Cholecystectomy
- Legal incapacity or limited legal capacity, legal safeguard
- Pregnant women
- Subject unlikely to cooperate in the study and/or low cooperation anticipated by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Besançon
Besançon, 25030, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul CALAME, MD
CHU de Besançon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2023
First Posted
January 30, 2023
Study Start
July 4, 2023
Primary Completion
September 19, 2024
Study Completion
September 19, 2024
Last Updated
September 23, 2024
Record last verified: 2024-09